Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer

References

• Addadi L, Weiner S. (1985). Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization. Proc Natl Acad Sci USA 82:4110–14.
   PubMed Web of Science ®Google Scholar
• Arnold RD, Slack JE, Straubinger RM. (2004). Quantification of doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. J Chromatogr B 808:141–52.
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. (2009). Turbiscan lab® expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B: Biointerfaces 72:155–60.
   PubMed Web of Science ®Google Scholar
• Chang Q, Geng R, Wang S, et al. (2016). DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting. Drug Deliv 23:3629–38.
   PubMed Web of Science ®Google Scholar
• Coleman RE. (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–76.
   PubMed Web of Science ®Google Scholar
• Currie GL, Delaney A, Bennett MI, et al. (2013). Animal models of bone cancer pain: systematic review and meta-analyses. Pain 154:917–26.
   PubMed Web of Science ®Google Scholar
• Gong W, Wang ZY, Liu N, et al. (2011). Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia. Biol Pharm Bull 34:1058–64.
   PubMed Web of Science ®Google Scholar
• Hao Z, Fan W, Hao J, et al. (2016). Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo. Drug Deliv 23:874–81.
   PubMed Web of Science ®Google Scholar
• Hortobagyi G. (1997). Anthracyclines in the treatment of cancer. Drugs 54:1–7.
   PubMed Web of Science ®Google Scholar
• Jiang B, Cao J, Zhao J, et al. (2012). Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation. Drug Deliv 19:317–26.
   PubMed Web of Science ®Google Scholar
• Karacivi M, Sumer Bolu B, Sanyal R. (2017). Targeting to the bone: alendronate-directed combretastatin A-4 bearing antiangiogenic polymer–drug conjugates. Mol Pharm 14:1373–83.
   PubMed Web of Science ®Google Scholar
• Leamon CP, Reddy JA. (2004). Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127–41.
   PubMed Web of Science ®Google Scholar
• Li MY, Li ZP, Yang Y, et al. (2016). Thermo-sensitive liposome co-loaded of vincristine and doxorubicin based on their similar physicochemical properties had synergism on tumor treatment. Pharm Res 33:1881–98.
   PubMed Web of Science ®Google Scholar
• Mayer LD, Tai LC, Ko DS, et al. (1989). Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49:5922–30.
   PubMed Web of Science ®Google Scholar
• Miller S, Pan H, Wang D, et al. (2008). Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. Pharm Res 25:2889–95.
   PubMed Web of Science ®Google Scholar
• Mundy GR. (2002). Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–93.
   PubMed Web of Science ®Google Scholar
• Murphy MB, Hartgerink JD, Goepferich A, Mikos AG. (2007). Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules 8:2237–43.
   PubMed Web of Science ®Google Scholar
• Neves M, Gano L, Pereira N, et al. (2002). Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies. Nucl Med Biol 29:329–38.
   PubMed Web of Science ®Google Scholar
• Thamake SI, Raut SL, Gryczynski Z, et al. (2012). Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials 33:7164–73.
   PubMed Web of Science ®Google Scholar
• Trombino S, Ferrarelli T, Pellegrino M, et al. (2013). Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells. Anticancer Res 33:4847–54.
   PubMed Web of Science ®Google Scholar
• Vermeirsch H, Nuydens RM, Salmon PL, Meert TF. (2004). Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity. Pharmacol Biochem Behav 79:243–51.
   PubMed Web of Science ®Google Scholar
• Vinay R, KusumDevi V. (2016). Potential of targeted drug delivery system for the treatment of bone metastasis. Drug Deliv 23:21–9.
   PubMed Web of Science ®Google Scholar
• Wang F, Chen L, Zhang R, et al. (2014). RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. J Control Release 196:222–33.
   PubMed Web of Science ®Google Scholar
• Weitman SD, Lark RH, Coney LR, et al. (1992). Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396–401.
   PubMed Web of Science ®Google Scholar
• Xiang B, Dong DW, Shi NQ, et al. (2013). PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials 34:4137–49.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang YF, Xie XY, et al. (2015). Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials 48:84–96.
   PubMed Web of Science ®Google Scholar
• Yokogawa K, Miya K, Sekido T, et al. (2001). Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. Endocrinology 142:1228–33.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cao H, Zhang J, et al. (2017). Comparative study of (Asp)7-CHOL-modified liposome prepared using pre-insertion and post-insertion methods for bone targeting in vivo. J Drug Target 25:149–55.
   PubMed Web of Science ®Google Scholar